Lymphocytes Cut Off Values of Induced Sputum Samples in Healthy &

Status Completed

Clinical Trial Summary

Background: Induced sputum (IS) is a noninvasive methodology for evaluating airway inflammation in a large number of pulmonary diseases, i.e, Asthma, Chronic obstructive pulmonary disease and Interstitial Lung Diseases. Several studies have defined normal values and cut-off points for this technique based on cellular components of IS, such as percentages of eosinophils, neutrophils, macrophages and CD4/CD8 ratio of T cell lymphocytes. However, normal values and cut-off points for lymphocyte percentages indicative of pathology have not yet been established or validated. This component of IS has considerable clinical value. Similar to other constituents of IS, it can provide biological insights into the pathogenesis of respiratory disorders and contribute to establishing the diagnosis and guiding treatment management of a variety of airway diseases.

The purposes of this study are to define normal values and cut-off points of lymphocytes in IS among individuals with respiratory disorders and healthy volunteers, and to verify the current reference values of the percentage of eosinophils, neutrophils and CD4/CD8 ratio in IS.

Methods: A Cross Sectional study which includes a database on up to 900 patients who participated in various studies conducted in the Pulmonary Laboratory of Tel Aviv Sourasky Medical Center between 2005 to 2012 will be established. The study population will include patients diagnosed as having various pulmonary diseases and a group of healthy volunteers who will serve as controls. The cut-off for normal values of lymphocyte, eosinophil and neutrophil percentages and CD4/CD8 ratio in IS will be defined by using ROC curves and evaluating sensitivity and specificity. The comparison of the different values to those in the literature will be done by using the Spearman rank correlation.

The results of this study will provide supplementary information on lymphocyte counts in IS for identifying and treating various respiratory diseases.

Clinical Trial Description

n/a

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Disorders of Environmental Origin
Occupational Diseases
Respiratory Tract Diseases

Clinical Trial Details

NCT number	NCT02093936
Study type	Observational [Patient Registry]
Source	Tel-Aviv Sourasky Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06004440` - Real World Registry for Use of the Ion Endoluminal System
Withdrawn	`NCT04842331` - PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)	Phase 2/Phase 3
Completed	`NCT02352168` - Airway Inflammation in Children With Allergic Rhinitis and Intervention	N/A
Completed	`NCT01860898` - A Phase I Study of iPS Cell Generation From Patients With COPD	N/A
Completed	`NCT00984945` - Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults	Phase 1
Completed	`NCT00382408` - A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001	Phase 3
Completed	`NCT01442779` - Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis	Phase 2
Recruiting	`NCT05907564` - Aventus Thrombectomy System Pulmonary Embolism Clinical Study	N/A
Not yet recruiting	`NCT05534685` - Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia	N/A
Completed	`NCT03739112` - Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly	Phase 3
Active, not recruiting	`NCT04170348` - Daily Vitamin D for Sickle-cell Respiratory Complications	Phase 2
Completed	`NCT05056766` - How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
Completed	`NCT01991587` - Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults	Phase 1/Phase 2
Recruiting	`NCT05565872` - Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD	N/A
Not yet recruiting	`NCT05592431` - Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Neonates	N/A
Completed	`NCT03401463` - Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar	N/A
Recruiting	`NCT02913365` - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis	N/A
Active, not recruiting	`NCT01055990` - Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients	Phase 2
Completed	`NCT00743990` - Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough	N/A
Completed	`NCT02198391` - Study of Echinaforce Junior Tablets in Children With Acute Colds

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Lymphocytes Cut Off Values of Induced Sputum Samples in Healthy and Non-healthy Patients- A Cross Sectional Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms